{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:55:10Z","timestamp":1773284110040,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":1456,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jmii.2011.11.010","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T15:15:00Z","timestamp":1326381300000},"page":"1-6","source":"Crossref","is-referenced-by-count":7,"title":["Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan"],"prefix":"10.1016","volume":"45","author":[{"given":"Yeu-Jun","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Tai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Sen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jien-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuarn-Jang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2011.11.010_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.11.010_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.jmii.2011.11.010_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijantimicag.2007.03.002","article-title":"Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia","volume":"30","author":"Hsueh","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2011.11.010_bib4","series-title":"Surgery: scientific principles and practice","first-page":"1246","article-title":"Acute abdomen and appendix","author":"Liu","year":"1997"},{"key":"10.1016\/j.jmii.2011.11.010_bib5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.micinf.2004.05.017","article-title":"Intra-abdominal infections","volume":"6","author":"Marshall","year":"2004","journal-title":"Microbes Infect"},{"issue":"suppl. 1","key":"10.1016\/j.jmii.2011.11.010_bib6","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/clind\/15.Supplement_1.S33","article-title":"Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration","volume":"15","author":"Solomkin","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"suppl. 2","key":"10.1016\/j.jmii.2011.11.010_bib7","first-page":"ii29","article-title":"Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy","volume":"53","author":"Goldstein","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00075198-200104000-00010","article-title":"Diagnosis of intra-abdominal infection in the critically ill patient","volume":"7","author":"Evans","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jmii.2011.11.010_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/109629602761624171","article-title":"The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary","volume":"3","author":"Mazuski","year":"2002","journal-title":"Surg Infect"},{"key":"10.1016\/j.jmii.2011.11.010_bib10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200565120-00002","article-title":"Critical issues in the clinical management of complicated intra-abdominal infections","volume":"65","author":"Blot","year":"2005","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2011.11.010_bib11","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1086\/341930","article-title":"Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.11.010_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.sla.0000230024.84190.a8","article-title":"Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections","volume":"244","author":"Malangoni","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jmii.2011.11.010_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/sur.2005.6.439","article-title":"In\u00a0vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"6","author":"Chow","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.jmii.2011.11.010_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jinf.2011.02.009","article-title":"Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria","volume":"62","author":"Chen","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2011.11.010_bib15","first-page":"317","article-title":"In\u00a0vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002\u20132006","volume":"42","author":"Chen","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2011.11.010_bib16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/AAC.48.3.1012-1016.2004","article-title":"In\u00a0vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections","volume":"48","author":"Edmiston","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10096-009-0801-x","article-title":"In\u00a0vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intra-abdominal infections at a medical center in Taiwan, 2001\u20132006","volume":"28","author":"Liu","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.11.010_bib18","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00355-08","article-title":"Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems","volume":"52","author":"Liu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10096-004-1199-0","article-title":"Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery","volume":"23","author":"Krobot","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.11.010_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.anaerobe.2007.09.005","article-title":"Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens","volume":"14","author":"Stein","year":"2008","journal-title":"Anaerobe"},{"key":"10.1016\/j.jmii.2011.11.010_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jac\/dkh173","article-title":"Moxifloxacin penetration into human gastrointestinal tissues","volume":"53","author":"Wirtz","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jac\/dkl305","article-title":"Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis","volume":"58","author":"Stass","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jac\/dkl353","article-title":"Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose","volume":"58","author":"Wacke","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00044011-200828020-00001","article-title":"Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess","volume":"28","author":"Rink","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jmii.2011.11.010_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1179\/joc.2009.21.2.170","article-title":"AIDA Study Group. Moxifloxacin for the treatment of patients with cIAI, the AIDA study","volume":"21","author":"Weiss","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2011.11.010_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijantimicag.2009.06.022","article-title":"DRAGON study team. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections","volume":"34","author":"Solomkin","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2011.11.010_bib27","series-title":"Efficacy and safety of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study","author":"De Waele","year":"2010"},{"key":"10.1016\/j.jmii.2011.11.010_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cir664","article-title":"Clinical efficacy and correlation of clinical outcomes with in\u00a0vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin","author":"Goldstein","year":"2011","journal-title":"Clin Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.jmii.2012.03.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000}}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T04:27:14Z","timestamp":1543292834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118211002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1684118211002118"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2011.11.010","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}